Show simple item record

dc.contributor.authorSerrano Regal, María Paz
dc.contributor.authorBayón Cordero, Laura
dc.contributor.authorOrdaz, Rainald Pablo
dc.contributor.authorGaray, Edith
dc.contributor.authorLimon, Agenor
dc.contributor.authorArellano, Rogelio O.
dc.contributor.authorMatute Almau, Carlos José
dc.contributor.authorSánchez Gómez, María Victoria ORCID
dc.date.accessioned2021-02-22T09:11:58Z
dc.date.available2021-02-22T09:11:58Z
dc.date.issued2020-08-21
dc.identifier.citationFrontiers in Cellular Neurosciences 14 : (2020) // Article ID 256es_ES
dc.identifier.issn1662-5102
dc.identifier.urihttp://hdl.handle.net/10810/50246
dc.description.abstractMyelin facilitates the fast transmission of nerve impulses and provides metabolic support to axons. Differentiation of oligodendrocyte progenitor cells (OPCs) and Schwann cell (SC) precursors is critical for myelination during development and myelin repair in demyelinating disorders. Myelination is tightly controlled by neuron-glia communication and requires the participation of a wide repertoire of signals, including neurotransmitters such as glutamate, ATP, adenosine, or gamma-aminobutyric acid (GABA). GABA is the main inhibitory neurotransmitter in the central nervous system (CNS) and it is also present in the peripheral nervous system (PNS). The composition and function of GABA receptors (GABARs) are well studied in neurons, while their nature and role in glial cells are still incipient. Recent studies demonstrate that GABA-mediated signaling mechanisms play relevant roles in OPC and SC precursor development and function, and stand out the implication of GABARs in oligodendrocyte (OL) and SC maturation and myelination. In this review, we highlight the evidence supporting the novel role of GABA with an emphasis on the molecular identity of the receptors expressed in these glial cells and the possible signaling pathways involved in their actions. GABAergic signaling in myelinating cells may have potential implications for developing novel reparative therapies in demyelinating diseases.es_ES
dc.description.sponsorshipThis work was supported by CIBERNED (CB06/05/0076; CM) and by grants from the Ministry of Economy and Competitiveness, Government of Spain (SAF2016-75292-R and PID2019-109724RB-I00; CM), Basque Government (IT1203-19; CM), CONACYT-Mexico (No. 252121; RA), PAPIIT-UNAM-Mexico (IN203519; RA) and NIH (R21AG053740 and R21MH113177; AL). MS-R was hired thanks to the Gangoiti Foundation (Bilbao). LB-C and RO hold fellowships from Basque Government and CONACYT-Mexico, respectively.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/SAF2016-75292-Res_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/PID2019-109724RB-I00es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectGABAes_ES
dc.subjectGABA receptores_ES
dc.subjectoligodendrocytees_ES
dc.subjectSchwann celles_ES
dc.subjectmyelinationes_ES
dc.subjectgamma-aminobutyric-acides_ES
dc.subjectoligodendrocyte precursor cellses_ES
dc.subjectpositive allosteric modulatores_ES
dc.subjectactivated protein-kinasees_ES
dc.subjectinternational uniones_ES
dc.subjectglial-cellses_ES
dc.subjectA receptores_ES
dc.subjectprogenitor cellses_ES
dc.subjectnervous-systemes_ES
dc.titleExpression and Function of GABA Receptors in Myelinating Cellses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2020 Serrano-Regal, Bayón-Cordero, Ordaz, Garay, Limon, Arellano, Matute and Sánchez-Gómez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fncel.2020.00256/fulles_ES
dc.identifier.doi10.3389/fncel.2020.00256
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2020 Serrano-Regal, Bayón-Cordero, Ordaz, Garay, Limon, Arellano, Matute and Sánchez-Gómez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Except where otherwise noted, this item's license is described as 2020 Serrano-Regal, Bayón-Cordero, Ordaz, Garay, Limon, Arellano, Matute and Sánchez-Gómez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.